Greenwich Wealth Management LLC Cuts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Greenwich Wealth Management LLC lowered its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 0.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,060 shares of the biotechnology company’s stock after selling 33 shares during the quarter. Axon Enterprise makes up 1.1% of Greenwich Wealth Management LLC’s portfolio, making the stock its 12th biggest holding. Greenwich Wealth Management LLC’s holdings in Axon Enterprise were worth $16,082,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in AXON. Geode Capital Management LLC grew its holdings in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP grew its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC grew its holdings in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new position in Axon Enterprise during the 3rd quarter valued at approximately $200,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the transaction, the president now owns 181,892 shares in the company, valued at $116,852,877.56. This represents a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,146 shares of company stock worth $3,262,847 in the last ninety days. 6.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms have weighed in on AXON. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Trading Up 4.1 %

AXON opened at $556.26 on Friday. The stock’s fifty day moving average is $593.42 and its two-hundred day moving average is $535.46. The company has a market capitalization of $42.62 billion, a P/E ratio of 143.74, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.